Zacks.com on MSN1d
Expanding Diabetes Business Supports ABT Stock, FX Issues Stay
Abbott’s ABT diversified business portfolio is well-positioned to drive continued momentum in 2025. Yet, the international ...
Stock market today: Wall Street rises to a record following a small gain for the S&P 500
U.S. stocks crept to a record as the S&P 500 nudged higher after a quiet Tuesday of trading. The main measure of Wall Street's health rose 0.2% to finish just above its all-time closing high set last ...
ANL and Aurizon partner on Landbridging through Darwin
Ships from Asian Pacific ports to Darwin, then connects directly to Adelaide by rail. • New alternative service offers ...
Zacks.com on MSN2d
Medtronic Q3 Earnings Top Estimates, Revenues Miss, Stock Tumbles
Medtronic plc MDT reported adjusted earnings per share (EPS) of $1.39 for the third quarter fiscal of 2025, up 6.9% from the ...
Healio6d
Automated insulin delivery lowers HbA1c, improves time in range in type 2 diabetes
Adults with insulin-treated type 2 diabetes had a significant HbA1c decline at 13 weeks with use of the Omnipod 5 automated ...
Stock market today: Wall Street finishes a winning week just shy of a record
Wall Street edged back from its all-time high on Friday, as U.S. stock indexes drifted following mixed profit reports from big companies. The S&P 500 barely budged and slipped by less than 0.1%, a day ...
Dexcom Q4 Earnings: Expanding Sales, New Products, Margin Pressure And More
Dexcom reported Q4 results, with revenue up 8%, beating estimates. CEO looks forward to unlocking next wave of global access.
health.economictimes.indiatimes6d
Dexcom beats fourth-quarter sales, reiterates 2025 revenue forecast
Sales: The California-based device maker is pinning its hopes on Stelo, its recently launched device for adults aged 18 and older who do not use insulin, making it the first CGM available for over-the ...